Cargando...
Development of Tivantinib as Treatment for Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a rapidly rising cause of liver-related death worldwide. Most patients are diagnosed at an advanced stage of disease, when systemic therapy is the only viable option for treatment. Significant strides have been made in the molecular understanding of HCC development...
Gardado en:
| Publicado en: | J Clin Transl Hepatol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
XIA & HE Publishing Ltd
2013
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4521271/ https://ncbi.nlm.nih.gov/pubmed/26355274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14218/JCTH.2013.00008 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|